These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17992117)

  • 1. Kinetic model of progression of cutaneous melanoma population.
    Gutkowicz-Krusin D; Rabinovitz HS
    Melanoma Res; 2007 Dec; 17(6):354-9. PubMed ID: 17992117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thin melanomas.
    King R; Googe PB; Mihm MC
    Clin Lab Med; 2000 Dec; 20(4):713-29. PubMed ID: 11221511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics.
    Schwartz JL; Wang TS; Hamilton TA; Lowe L; Sondak VK; Johnson TM
    Cancer; 2002 Oct; 95(7):1562-8. PubMed ID: 12237926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A; Young DS; Ghazarian D; Neligan PC
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features.
    Elder DE; Gimotty PA; Guerry D
    Dermatol Ther; 2005; 18(5):369-85. PubMed ID: 16297012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
    Shaikh WR; Xiong M; Weinstock MA
    Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
    Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic signs in melanoma: state of the art.
    Lomuto M; Calabrese P; Giuliani A
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):291-300. PubMed ID: 15096138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma.
    Altamura D; Avramidis M; Menzies SW
    Arch Dermatol; 2008 Apr; 144(4):502-6. PubMed ID: 18427044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive malignant melanomas lacking competence for metastasis.
    Elder DE; Guerry D; Epstein MN; Zehngebot L; Lusk E; Van Horn M; Clark WH
    Am J Dermatopathol; 1984; 6 Suppl():55-61. PubMed ID: 6528943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
    Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
    Einwachter-Thompson J; MacKie RM
    Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma screening clinics: are we detecting more melanomas or reassuring the worried well?
    Weatherhead SC; Lawrence CM
    Br J Dermatol; 2006 Mar; 154(3):539-41. PubMed ID: 16445788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of melanoma-in-situ using a staged marginal and central excision technique.
    Möller MG; Pappas-Politis E; Zager JS; Santiago LA; Yu D; Prakash A; Kinal A; Clark GS; Zhu W; Puleo CA; Glass LF; Messina JL; Sondak VK; Cruse CW
    Ann Surg Oncol; 2009 Jun; 16(6):1526-36. PubMed ID: 19050971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in melanoma epidemiology suggest three different types of melanoma.
    Lipsker D; Engel F; Cribier B; Velten M; Hedelin G
    Br J Dermatol; 2007 Aug; 157(2):338-43. PubMed ID: 17596175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
    Uliasz A; Lebwohl M
    Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland.
    Montella A; Gavin A; Middleton R; Autier P; Boniol M
    Eur J Cancer; 2009 Sep; 45(13):2360-6. PubMed ID: 19375307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.